MERK Merck Tbk


Saham MERK Merck Tbk - Berita, Prospek, dan Analisa - :
Stocks Asia - Berita saham, analisis saham, dan prospek saham
Tip: Gunakan untuk menyimpan saham-saham favorit
MERK SCPI Merck Sharp Dohme Pharma (SCPI) Ganti Nama Organon Pharma Indonesia Tbk. – EmitenNews
18 Feb 2021 15:05 (6 hari lalu) - EmitenNews.com- Perusahaan farmasi PT. Merck Sharp Dohme Pharma Tbk. (SCPI) telah melakukan perubahan nama menjadi PT. Organon Pharma Indonesia Tbk. pada tanggal 15 Februari 2021. Baca juga: Merck Sharp Dohme Pharma (SCPI) Belum Pastikan Rencana Go Private Terealisasi Menurut keterangan tertulis dari Erwin Agung Direktur SCPI menyampaikan bahwa sebagaimana termuat dalam Akta Notaris No. 18 tanggal 6 Januari 2021 Jimmy Tanal SH S.H., M.KN., yang telah memperoleh persetujuan dari Menkumham RI dengan Surat keputusan No. AHU-AH.01.03-0024717 tanggal 15 Januari 2021. Erwin menyampaikan “Adapun dokumen pendukung lainnya seperti NIB (nomor izin b ...
MERK 5 Affordable Biopharma Stocks With Growth Potential - MarketWatch
18 Feb 2021 00:06 (7 hari lalu) - Big biopharmaceutical stocks have trailed the broader market over the past 12 months, with the S&P 500 Pharmaceuticals index up 6.2% over the past 12 months while the broader S&P 500 has risen 16.6%. But smaller biotech stocks have soared over the same period, with the iShares Nasdaq Biotechnology ETF (ticker: IBB) up 38%, driven by enthusiasm over Covid-19 treatments and vaccines. For investors looking for value among mature, larger-cap biopharmaceutical companies, the search can be tough. Shares of stalwarts like Eli Lilly (LLY) and Johnson & Johnson (JNJ) have climbed in recent months, with Lilly up 21.1% so far in 2021, and Johnson & Jo ...
MERK Laporan Bulanan Registrasi Pemegang Efek
MERK Frazier Pensiun Akhir Juni Mendatang
05 Feb 2021 08:44 (19 hari lalu) - Pasardana.id- CEO perusahaan farmasi Merck, Kenneth Frazier, pada Kamis (4/2/2021) dikabarkan akan pensiun pada akhir Juni mendatang. Frazier akan digantikan oleh Robert Davis yang saat ini menjabat sebagai CFO Merck. Seperti dilansir BBC News, Frazier merupakan salah satu dari empat CEO perusahaan Fortune 500 yang berkulit hitam. Pria berusia 66 tahun tersebut bergabung dengan Merck pada 1992 dan mulai menjadi CEO pada 2011. Pada 2017, Frazier mengejutkan publik setelah mengundurkan diri dari dewan manufaktur yang dibentuk pemerintah Amerika Serikat karena Donald Trump yang menjabat sebagai Presiden AS pada saat itu menolak untuk membubark ...
MERK Merck Announces New CEO, But Reports Earnings Miss - MarketWatch
04 Feb 2021 19:56 (20 hari lalu) - Drug company Merck announced Thursday that its CEO, Kenneth Frazier, would retire at the end of June after a decade leading the company. Merck’s current executive vice president, Robert Davis, will succeed him. Frazier’s departure is long-awaited, and the company has been previewing its succession planning for years. Davis seems an obvious successor: He served as Merck’s (ticker: MRK) chief financial officer after joining the drug company in 2014, until his responsibilities were expanded in 2016. He is a highly-respected leader and among the highest-profile health-care executives in the country. According to Fortune, Frazier is one of only ...
MERK U.S. drugmaker Merck's Kenneth Frazier to step down as CEO By Reuters
04 Feb 2021 19:22 (20 hari lalu) - (Reuters) - Merck & Co said on Thursday Kenneth Frazier, one of only a handful of Black CEOs leading major U.S. companies, would step down as chief executive officer at the end of June to be replaced by Chief Financial Officer Robert Davis. Frazier, 66, will continue to serve on Merck's board as executive chairman for a transition period to be determined by the board, the company said. The company's stock price has doubled since he took the helm in 2011. A career pharmaceutical industry executive, Davis joined Merck as CFO in 2014 and took on added responsibilities in 2016 to include the company’s global support functions. Under Frazier's ...
MERK Exclusive: Merck anti-baldness drug Propecia has long trail of suicide reports, records show By Reuters
04 Feb 2021 03:21 (21 hari lalu) - By Dan Levine and Chad Terhune (Reuters) - Newly unsealed court documents and other records show that Merck & Co and U.S. regulators knew about reports of suicidal behavior in men taking the company’s anti-baldness treatment Propecia when they decided not to warn consumers of those potential risks in a 2011 update of the popular drug’s label. Internal records from Merck were made public in late January, when a federal magistrate in Brooklyn, New York, granted a 2019 Reuters motion to unseal 11 documents filed in years of litigation alleging Propecia caused persistent sexual dysfunction and other harmful side effects. Since the 2011 decisio ...
MERK Vaksin Covid-19 Gagal di Uji Klinis Awal, Merck Lempar Handuk - Tekno Tempo.co
27 Jan 2021 11:25 (28 hari lalu) - Ilustrasi vaksin COVID-19 atau virus corona. REUTERS/Dado Ruvic TEMPO.CO, Jakarta- Merck mengumumkan pada Senin 25 Januari 2021 kalau akan berhenti mengembangkan dua formula vaksin Covid-19 yang sedang dikerjakannya. Penyebabnya, respons kekebalan tubuh yang tidak sesuai dengan yang diharapkan dari fase awal uji klinis kedua formula itu. Pengumuman itu mengejutkan karena Merck, perusahaan farmasi multinasional berbasis di Amerika Serikat, termasuk pembuat vaksin terkenal di dunia. Namun Merck menegaskan tetap akan berkomitmen dalam penelitian Covid-19 dan akan memberi fokus kepada dua potensi obat penyakit infeksi itu yang juga sedang dikem ...
MERK GE and Other Industrial Stocks Are Jumping After Earnings. Why That’s Great News for the Economy. - MarketWatch
26 Jan 2021 20:11 (29 hari lalu) - Worried about the state of the economy? Stop now and look at industrial company earnings. Four industrial titans reported Tuesday morning, and all four offered results and guidance that should get investors excited about where the economy is going. General Electric, for starters, reported better-than-expected free cash flow, and said it’s targeting about $3.5 billion in free cash flow from industrial operations in 2021, much better than Wall Street expected. Its stock has jumped 7%. 3M, meanwhile, cruised by estimates and gave 2021 guidance in line with Street expectations and about 75 cents better than the $8.74 in per-share earnings gener ...
MERK It Was a Grim Morning in the Covid-19 Fight. The Market Is Looking to Johnson & Johnson for Hope. - MarketWatch
26 Jan 2021 03:17 (1 bulan 12 menit lalu) - Late last week, for a brief moment the pandemic felt like it might be on the way to being under control. Yes, daily Covid-19 death counts were at near-record levels. But the vaccination rate was ticking above a million shots a day, Dr. Fauci was back behind the White House lectern, and the new president had a new plan for beating back the virus. Then Monday came, and reality hit. First came the news that Merck (ticker: MRK) was giving up on the two Covid-19 vaccines it had been testing. Then Moderna (MRNA) said its vaccine appears less effective against a new strain of the virus that causes Covid-19. The S&P 500 dropped 1.2% Monday morning ...
Mode seleksi ketat (strict search) ON. Klik di sini untuk melihat lebih banyak artikel.
  Artikel 1 sampai 10